Skip to content
2000
image of The Investigation of the Effect of a Dandelion Herbal Capsule (GHASEDAK Capsule) on Fibrosis and Liver Function in NAFLD: A Randomized, Double Blind, Placebo-controlled, Single-center Clinical Trial

Abstract

Introduction

Non-alcoholic fatty liver disease (NAFLD) is a major health problem with a high incidence rate. Dandelion (Taraxacum peregrinum), a member of the Asteraceae family, is widely used in traditional medicine for its therapeutic properties. This study aimed to evaluate the effect of GHASEDAK dandelion herbal capsules on liver fibrosis and function in patients with NAFLD.

Methods

This was a randomized, double-blind, placebo-controlled, single-center clinical trial. 50 eligible patients (25 per group) with grade 2 or 3 NAFLD (confirmed by laboratory tests and ultrasound) were randomized to receive either 300 mg dandelion capsules (900 mg/day; 3 capsules) or a matching placebo for 12 weeks, alongside lifestyle manner. Liver fibrosis (FibroScan®) and liver enzyme levels were assessed at baseline and after the intervention. Data were analyzed using t-tests and chi-square tests.

Results

In the dandelion group, mean liver fibrosis decreased from 6.97±1.57 to 5.87±1.36 (<0.0001). Alanine aminotransferase (ALT) decreased from 62.52±21.24 to 41.92±12.35, and aspartate aminotransferase (AST) from 46.68±18.01 to 28.24±8.07 (both P<0.0001).

Conclusion

Daily consumption of 900 mg of dandelion capsules, combined with lifestyle modification, significantly reduced liver fibrosis and serum liver enzyme levels in patients with NAFLD compared with the control group.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdth/10.2174/0115748855419340251113172731
2026-01-22
2026-02-02

  • From This Site

    /content/journals/cdth/10.2174/0115748855419340251113172731
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Sakaguchi S. Takahashi S. Sasaki T. Kumagai T. Nagata K. Progression of alcoholic and non-alcoholic steatohepatitis: Common metabolic aspects of innate immune system and oxidative stress. Drug Metab. Pharmacokinet. 2011 26 1 30 46 10.2133/dmpk.DMPK‑10‑RV‑087 21150132
    [Google Scholar]
  2. Cornier M.A. Dabelea D. Hernandez T.L. The metabolic syndrome. Endocr. Rev. 2008 29 7 777 822 10.1210/er.2008‑0024 18971485
    [Google Scholar]
  3. Milazzo S. Lejeune S. Ernst E. Laetrile for cancer: A systematic review of the clinical evidence. Support. Care Cancer 2007 15 6 583 595 10.1007/s00520‑006‑0168‑9 17106659
    [Google Scholar]
  4. Burlamaqui I.M.B. Dornelas C.A. Valença J.T. Mesquita F.J.C. Veras L.B. Rodrigues L.V. Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in Wistar rats. Arq. Gastroenterol. 2011 48 2 153 158 10.1590/S0004‑28032011000200012 21709958
    [Google Scholar]
  5. Savadkouhi F. HosseiniTabatabaei M, Nezhad SS. The frequency of fatty liver in sonography of patients without liver diseases background and its correlation with blood cholesterol and triglyceride. Zahedan J. Res. Med. Sci. 2003 5 3
    [Google Scholar]
  6. Adibi A. Kelishadi R. Beihaghi A. Salehi H. Talaei M. Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan. Endokrynol. Pol. 2009 60 1 14 19 [PMID: 19224500
    [Google Scholar]
  7. Feldman M. Friedman L.S. Brandt L.J. Sleisenger And Fordtran’s Gastrointestinal And Liver Disease E-book: Pathophysiology, Diagnosis, Management. Canada Elsevier Health Sciences 2020
    [Google Scholar]
  8. Wong V.W-S. Wong G.L-H. Chim A.M-L. Tse A.M-L. Tsang S.W-C. Hui A.Y. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am. J. Gastroenterol. 103 7 1682 1688 10.1111/j.1572‑0241.2008.01933.x
    [Google Scholar]
  9. Guha I.N. Parkes J. Roderick P.R. Harris S. Rosenberg W.M. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut 2006 55 11 1650 1660 10.1136/gut.2006.091454 17047111
    [Google Scholar]
  10. Tilg H. Moschen A.R. Evolving therapies for non-alcoholic steatohepatitis. Expert Opin. Drug Discov. 2014 9 6 687 696 10.1517/17460441.2014.911283 24766298
    [Google Scholar]
  11. Takahashi Y. Sugimoto K. Inui H. Fukusato T. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 2015 21 13 3777 3785 10.3748/wjg.v21.i13.3777 25852263
    [Google Scholar]
  12. He W. Han H. Wang W. Gao B. Anti-influenza virus effect of aqueous extracts from dandelion. Virol. J. 2011 8 1 538 10.1186/1743‑422X‑8‑538 22168277
    [Google Scholar]
  13. Chatterjee S.J. Ovadje P. Mousa M. Hamm C. Pandey S. The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells. Evid. Based Complement. Alternat. Med. 2011 2011 1 129045 10.1155/2011/129045 21234313
    [Google Scholar]
  14. Park C. Zhou Y. Song Y. Hepatoprotective effect of dandelion (Taraxacum officinale) against acute liver injury induced by Carbon tetrachloride in Sprague‐Dawley rats. Hoboken, New Jersey Wiley Online Library 2007 10.1096/fasebj.21.6.A1122‑d
    [Google Scholar]
  15. Han H. He W. Wang W. Gao B. Inhibitory effect of aqueous dandelion extract on HIV-1 replication and reverse transcriptase activity. BMC Complement. Altern. Med. 2011 11 1 112 10.1186/1472‑6882‑11‑112 22078030
    [Google Scholar]
  16. Jia Y.Y. Guan R.F. Wu Y.H. Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells. Mol. Med. Rep. 2014 9 4 1381 1387 10.3892/mmr.2014.1925 24481875
    [Google Scholar]
  17. Abolhasani H. Abolhasani A. Nojavan F. Ghahremani M. Heidari F. The growth inhibition effect of different extracts of Taraxacum peregrinum leaves on breast cancer cell line MDA-MB-468. Qom Univ Med Sci J 2022 17 10.32598/qums.17.1948.2
    [Google Scholar]
  18. Abolhasani A. Abolhasani H. Antifungal evaluation of aqueous and ethanolic extract of Iranian dandelion root (Taraxacum peregrinium) in comparison with fluconazole and nystatin. Unknown J 2021
    [Google Scholar]
  19. Akhzari A. Abolhasani H. A comparison between Taraxacum pregrinium anticancer activity and Cisplatin against human MCF7 and Hek293 cancer cell lines. The 4th International Congress on Bi-oMedicine (ICB2020). Tehran, Iran, November 2020
    [Google Scholar]
  20. Quer PF Davit S Plantas medicinales: El Dioscórides renovado 1993
    [Google Scholar]
  21. Lewis W.H. Elvin-Lewis M.P. Medical botany: Plants affecting human health. Hoboken, New Jersey John Wiley & Sons 2003
    [Google Scholar]
  22. Mahesh A. Jeyachandran R. Cindrella L. Thangadurai D. Veerapur V. Muralidhara Rao D. Hepatocurative potential of sesquiterpene lactones of Taraxacum officinale on carbon tetrachloride induced liver toxicity in mice. Acta Biol. Hung. 2010 61 2 175 190 10.1556/ABiol.61.2010.2.6 20519172
    [Google Scholar]
  23. Clare B.A. Conroy R.S. Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J. Altern. Complement. Med. 2009 15 8 929 934 10.1089/acm.2008.0152 19678785
    [Google Scholar]
  24. Kemper K.J. Dandelion (Taraxacum officinalis). Longwood Herb Task Force. Canada Longwood Herbal Task Force 1999
    [Google Scholar]
  25. Garcيa-Carrasco B Fernandez-Dacosta R Dávalos A Ordovás J Rodriguez-Casado A In vitro hypolipidemic and antioxidant effects of leaf and root extracts of Taraxacum officinale. Med. Sci. 2015 3 2 38 54 10.3390/medsci3020038 29083390
    [Google Scholar]
  26. Ivanov I.G. Polyphenols content and antioxidant activities of Taraxacum officinale FH Wigg (dandelion) leaves. Int. J. Pharmacogn. Phytochem. Res. 2014 6 889 893
    [Google Scholar]
  27. Sigstedt S. Hooten C. Callewaert M. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int. J. Oncol. 2008 32 5 1085 1090 10.3892/ijo.32.5.1085 18425335
    [Google Scholar]
  28. Hamaguchi M. Kojima T. Takeda N. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005 143 10 722 728 10.7326/0003‑4819‑143‑10‑200511150‑00009 16287793
    [Google Scholar]
  29. Sarafidis P.A. Nilsson P.M. The metabolic syndrome: A glance at its history. J. Hypertens. 2006 24 4 621 626 10.1097/01.hjh.0000217840.26971.b6 16531786
    [Google Scholar]
  30. Jang H.H. Park M.Y. Kim H.W. Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation. Nutr. Metab. 2012 9 1 27 10.1186/1743‑7075‑9‑27 22458550
    [Google Scholar]
  31. Baser K. Aromatic plants as a source of botanicals. Proc IV Int Conf Quality Safety Issues Related to Botanicals 720 Mississippi, USA, Aug 15-18 2005 27 33
    [Google Scholar]
  32. Bradbury M.W. Lipid metabolism and liver inflammation. i. hepatic fatty acid uptake: Possible role in steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006 290 2 G194 G198 10.1152/ajpgi.00413.2005 16407588
    [Google Scholar]
  33. Koh Y.J. Cha D.S. Ko J.S. Park H.J. Choi H.D. Anti-inflammatory effect of Taraxacum officinale leaves on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells. J. Med. Food 2010 13 4 870 878 10.1089/jmf.2009.1249 20673058
    [Google Scholar]
  34. Râcz-Kotilla E. Râcz G. Solomon A. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med. 1974 26 7 212 217 10.1055/s‑0028‑1099379 4427955
    [Google Scholar]
  35. Cho S.Y. Park J.Y. Park E.M. Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin. Chim. Acta 2002 317 1-2 109 117 10.1016/S0009‑8981(01)00762‑8 11814465
    [Google Scholar]
  36. Park C.M. Cha Y.S. Youn H.J. Cho C.W. Song Y.S. Amelioration of oxidative stress by dandelion extract through CYP2E1 suppression against acute liver injury induced by carbon tetrachloride in sprague‐dawley rats. Phytother. Res. 2010 24 9 1347 1353 10.1002/ptr.3121 20812277
    [Google Scholar]
  37. Davaatseren M. Hur H.J. Yang H.J. Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food Chem. Toxicol. 2013 58 30 36 10.1016/j.fct.2013.04.023 23603008
    [Google Scholar]
  38. Domitrović R. Jakovac H. Tomac J. Šain I. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol. Appl. Pharmacol. 2009 241 3 311 321 10.1016/j.taap.2009.09.001 19747501
    [Google Scholar]
/content/journals/cdth/10.2174/0115748855419340251113172731
Loading
The Investigation of the Effect of a Dandelion Herbal Capsule (GHASEDAK Capsule) on Fibrosis and Liver Function in NAFLD: A Randomized, Double Blind, Placebo-controlled, Single-center Clinical Trial
Bentham Science Publishers ; https://doi.org/10.2174/0115748855419340251113172731
/content/journals/cdth/10.2174/0115748855419340251113172731
/content/journals/cdth/10.2174/0115748855419340251113172731
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: alanine aminotransferase ; FibroScan ; Non-alcoholic fatty liver disease (NAFLD) ; GHASEDAK ; Dandelion herbal capsule ; aspartate aminotransferase

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test